VRTX
Vertex Pharmaceuticals Incorporated
$426.76
+$4.44(+1.05%)
45
Overall
45
Value
45
Tech
--
Quality
Market Cap
$110.50B
Volume
1.92M
52W Range
$362.50 - $519.68
Target Price
$490.77
EPS Estimates Overview
| Current Quarter | $4.32 | Next Quarter | $4.12 |
| Current Year | $15.99 | Next Year | $17.39 |
| QoQ Growth | -4.6% | YoY Growth | +8.8% |
| 3Y EPS CAGR | -30.6% | Target Price | $490.77 |
| Consensus | Buy | Upside | +15.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $426.76 | +1.1% | 1.92M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW